Publications by authors named "E Mikhael"

Background: Interdisciplinary collaboration among academic pharmacists is crucial for enhancing scientific research, discovering new drugs and modifying existing ones, besides solving pharmaceutical problems. This study aimed to explore the perception and experience of academic pharmacists regarding research collaboration.

Methods: A qualitative study through one-to-one face-to-face interviews with faculty members at the University of Baghdad/College of Pharmacy was conducted from May to July/2023.

View Article and Find Full Text PDF

Cancer-associated thrombosis (CAT) can increase morbidity and mortality for cancer patients. Therefore, guidelines recommend predicting VTE risk and thromboprophylaxis for high-risk patients. Many studies critique oncologists' adherence to thromboprophylaxis guidelines for cancer patients.

View Article and Find Full Text PDF

Sertraline, a selective serotonin reuptake inhibitor, is a medication recommended as a third line treatment of cholestatic liver injury pruritis. We report a case of a young male who developed liver injury secondary to self-administration of anabolic steroids and who complained of persistent pruritis leading to a treatment by sertraline. Two days later, the patient was admitted to the hospital with a severe hypoglycemia, while the liver function tests were in amelioration.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the experiences and perceptions of Iraqi pharmacists regarding substance use disorder, highlighting its prevalence among young males and the common misuse of pregabalin.
  • Interviews with 21 pharmacists revealed challenges they face, including societal issues like poverty, limited regulation enforcement, and fear of repercussions when addressing substance misuse.
  • Most pharmacists expressed a need for enhanced training and support to improve their capabilities in managing and preventing substance use disorders effectively.
View Article and Find Full Text PDF

Rheumatic diseases are common progressive diseases that associated with chronic pain. Most patients seek to reduce the pain of these diseases by using dietary supplements (DS). Yet, most DS have limited benefits to reduce pain and/or disease progression.

View Article and Find Full Text PDF